Fox Rothschild provides comprehensive representation to established and emerging life sciences companies, including pharmaceutical, medical device, biotechnology, therapeutic and diagnostic entities, as well as companies that serve the life science industry. Our interdisciplinary team of attorneys helps clients at all stages of development to navigate the uncertain and ever-changing regulatory environment and gain access to the capital they need to fund and expand their businesses. We provide representation in connection with intellectual property, technology transfer and university spin-outs, venture capital and finance, regulatory and compliance and mergers and acquisitions. The group also includes attorneys with experience in complying with FDA regulations.